LETITIA AYALA: Open Payments
NPI 1679234819 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 8 payments from 6 companies in 2025. Trend: 2023 $399 · 2024 $442 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Alnylam Pharmaceuticals Inc. | 1 | $41 |
| BridgeBio Pharma, Inc. | 1 | $31 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $19 |
| CVRx, Inc. | 1 | $11 |
Products named: LEQVIO, AMVUTTRA, Attruby, NEXLETOL, ENTRESTO, WATCHMAN FLX, Barostim Neo System.
Industry payments across FL — which companies pay providers there.
